Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-06-27

FDA Approved: ZIRABEV — Original Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approves ZIRABEV (bevacizumab-bvzr) from Pfizer as a biosimilar to Avastin under an Original Application. The approval covers multiple bevacizumab-indicated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZIRABEV (BEVACIZUMAB-BVZR)

Snippet

ORIG AP for ZIRABEV (BEVACIZUMAB-BVZR)